# A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

> **NCT02449889** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 176 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** highly purified human chorionic gonadotropin
- **DRUG:** recombinant human chorionic gonadotropin

## Key facts

- **NCT ID:** NCT02449889
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-07-09
- **Final completion:** 2018-03-01
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02449889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02449889, "A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02449889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*